Crossmark

Empiric antimicrobial therapy in the intensive care unit based on the risk of multidrug-resistant bacterial infection: a single-centre case‒control study of blood culture results in Japan

Crossref DOI link: https://doi.org/10.1186/s13756-023-01303-2

Published Online: 2023-09-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nanao, Taikan

Nishizawa, Hideo

Fujimoto, Junichi
License Information

Text and Data Mining valid from 2023-09-12

Version of Record valid from 2023-09-12
More Information

Article History

Received: 12 May 2023

Accepted: 31 August 2023

First Online: 12 September 2023

Declarations

:

: Institutional approval was obtained from the Yokohama Rosai Hospital Ethics Committee (approval number 2021-18). Informed consent was obtained in an opt-out format.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below